Tolcher, A. W., Rodrigueza, W. V., Rasco, D. W., Patnaik, A., Papadopoulos, K. P., Amaya, A., . . . Messmann, R. A. (2013). A phase 1 study of the BCL2-targeted deoxyribonucleic acid inhibitor (DNAi) PNT2258 in patients with advanced solid tumors. Springer Berlin Heidelberg.
Citação norma ChicagoTolcher, Anthony W., et al. A Phase 1 Study of the BCL2-targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 in Patients With Advanced Solid Tumors. Springer Berlin Heidelberg, 2013.
MLA引文Tolcher, Anthony W., et al. A Phase 1 Study of the BCL2-targeted Deoxyribonucleic Acid Inhibitor (DNAi) PNT2258 in Patients With Advanced Solid Tumors. Springer Berlin Heidelberg, 2013.
警告:這些引文格式不一定是100%准確.